Sandoz Group (OTCMKTS:SDZNY) Sees Large Volume Increase – What’s Next?

Shares of Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY) saw unusually-strong trading volume on Wednesday . 47,894 shares were traded during trading, an increase of 55% from the previous session’s volume of 30,840 shares.The stock last traded at $85.18 and had previously closed at $79.32.

Analyst Upgrades and Downgrades

Separately, Barclays raised shares of Sandoz Group from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, May 5th. Three research analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, Sandoz Group has a consensus rating of “Strong Buy”.

Sandoz Group Stock Performance

The company has a debt-to-equity ratio of 0.53, a current ratio of 1.18 and a quick ratio of 0.77. The stock has a 50-day moving average price of $83.42 and a two-hundred day moving average price of $82.46.

About Sandoz Group

Sandoz Group (OTCMKTS:SDZNY) is a multinational pharmaceutical company focused on the development, manufacturing and commercialization of generic medicines and biosimilars. The company supplies off-patent small-molecule drugs as well as biologic alternatives intended to offer lower-cost therapeutic options across a range of clinical areas. Sandoz emphasizes access and affordability, positioning its portfolio to serve hospitals, pharmacies and health systems looking to expand patient access to essential therapies.

The company’s product offerings span conventional generics, complex and specialty generics, and a growing pipeline of biosimilar medicines.